Bioanalytical Testing Services Market Size and Forecasts, Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Services ; Disease Indication ; End User, and Geography

Description

List of Tables

The global bioanalytical testing services market is expected to reach US$ 10,108.82 million in 2030 from US$ 4,641.13 million in 2022. The market is estimated to grow with a CAGR of 10.2% from 2022 to 2030.

The key factors driving the market's growth are increasing outsourcing of R&D activities by pharmaceutical companies and the high demand for analytical testing of biosimilars and biologics. However, challenges in developing and validating bioanalytical methods are hampering the market's growth to a certain extent.

Market Opportunities of Bioanalytical Testing Services Market

The research & development, production, and distribution of medicinal drugs and other pharmaceutical products are the major areas of the pharmaceutical industry. Global pharmaceutical consumption is rising with the increasing need for drugs to treat age-related diseases and chronic diseases. According to the WHO, the elderly population aged 60 or above is projected to double from 2020 to 2050, reaching ~2.1 billion by 2050. A rise in the geriatric population would contribute to a surge in incidences of chronic diseases, such as cardiovascular diseases, cancer, hypertension, osteoarthritis, and diabetes mellitus. Thus, chronic diseases have been a major area of focus for pharmaceutical companies.

New drug development is a resource-, cost-, and time-intensive process, where later clinical stages result in significant costs. As per the United States Congressional Budget Office (CBO), it takes over 10-15 years and costs around US$ 1-2 billion to discover a drug and obtain regulatory approval. Therefore, to lower the attrition rate in drug research & development, pharmaceutical companies are focusing on following the good manufacturing practices (GMP) set by the US FDA and other major regulatory organizations. Several pharmaceutical companies are opting for bioanalytical testing services for drug development and validation of assays in both clinical and preclinical stages. Generics and branded drug compounds are mostly small molecules. Generics manufacturers conduct and submit bioanalytical testing results to overcome the issue of patent expiration. Thus, with the uninterrupted proliferation of the pharmaceutical industry, bioanalytical testing service providers are likely to experience a continuous rise in demand for their services in the future, which would lead to new growth opportunities in the bioanalytical testing services market.

Factors Hampering Bioanalytical Testing Services Market

Developing bioanalytical methods is a complex process that necessitates a dexterous approach by skilled professionals. As a result, several challenges are associated with the development and validation of biological analysis methods. According to Simbec-Orion, a UK-based clinical research organization for complex clinical studies, FDA reviewers have outlined challenges such as analytical issues, flawed extraction techniques, calculation problems, reporting issues, and sample shipping issues related to bioanalytical testing methods. Various analytical issues may arise during the sample preparation and analysis stage; these include deterioration of analytical columns in HPLC; contamination in the mobile phase; issues arising from the complexity of sample matrices in LCMS; and contamination of other stages of LCMS. These hamper the bioanalytical test validation and simultaneously affect the quality standards, thereby limiting the growth of the bioanalytical testing services market.

Bioanalytical Testing Services Market: Segmental Overview

Based on services, the bioanalytical testing services market is segmented into pharmacokinetics, biomarkers, immunogenicity, virology testing, cell-based assays, and others. The cell-based assays segment held the largest market share in 2022. Furthermore, the same segment is anticipated to register the highest CAGR from 2022 to 2030. Cell-based assays are commonly used to determine the biological activity (potency) of the drug product or drug substance and discover the mechanism of action (MOA), as well as for cytotoxicity testing and early-stage proof-of-principal studies. While in immunogenicity studies, it helps in determining drug neutralization effect of antibodies produced in the patient's body.

Based on disease indication, the bioanalytical testing services market is segmented into cardiovascular, neurological disorders (CNS), metabolic disorders, oncology, sexual health, bone disease, and others. In 2022, the oncology segment held the market's largest share. Also, the same segment is expected to grow in demand at the fastest CAGR from 2022 to 2030, owing to the advances in oncology for pain relief, chemotherapy, and other therapies.

Based on end users, the bioanalytical testing services market is segmented into pharmaceutical and biopharmaceutical companies, contract research organizations (CRO), contract development and manufacturing organization (CDMO), and others. In 2022, the pharmaceutical and biopharmaceutical companies segment held the largest market share. Furthermore, the same segment is expected to witness growth in demand at the fastest CAGR from 2022 to 2030. The bioanalytical test services aim to eliminate the risks involved from the beginning of the pharmaceutical production to the final product release. Thus, the cruciality of bioanalytical testing services in drug discovery and development drives the bioanalytical testing services market for the pharmaceutical and biopharmaceutical companies segment.

Bioanalytical Testing Services Market: Geographical Overview

North America holds the largest share of the global bioanalytical testing services market, whereas the Asia Pacific is the fastest-growing region. The market in North America is expected to grow during the forecast period owing to the uninterrupted growth of the pharmaceuticals industry, the increasing need for developing novel drugs due to an upsurge in the incidences of various diseases, rising healthcare expenditure by governments, and a growing preference for outsourcing activities for the quality assurance of pharmaceutical products. Asia Pacific registered the highest CAGR in the global bioanalytical testing services testing market. The market in the region is expected to grow significantly in countries, including China, India, and Japan, in the coming years. The Asia Pacific market is expected to grow due to the increasing demand for outsourcing services in the low-cost labor markets. Therefore, the region holds huge potential for the bioanalytical testing services market players to grow during the forecast period.

A few of the major primary and secondary sources referred to while preparing the report on the bioanalytical testing services market are the World Bank Data, National Health Service (NHS), FDA (Food and Drug Administration), EMA (European Medicines Agency), and EPA (Environmental Protection Agency).

Reasons to Buy:

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in thebioanalytical testing services market.
Highlights key business priorities in order to assist companies to realign their business strategies.
The key findings and recommendations highlight crucial progressive industry trends in the globalbioanalytical testing services market, thereby allowing players across the value chain to develop effective long-term strategies.
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
Scrutinize in-depth global market trends and outlook coupled with the factors driving thebioanalytical testing services market, as well as those hindering it.
Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing, and distribution.

Product Code: TIPRE00007336

1. Introduction

1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. Bioanalytical Testing Services Market Landscape

4.1 Overview
4.2 PEST Analysis
- 4.2.1 North America PEST Analysis
- 4.2.2 Europe PEST Analysis
- 4.2.3 Asia Pacific PEST Analysis
- 4.2.4 South & Central America PEST Analysis
- 4.2.5 Middle East & Africa PEST Analysis

5. Bioanalytical Testing Services Market - Key Industry Dynamics

5.1 Key Market Drivers:
- 5.1.1 Increasing Outsourcing of R&D Activities by Pharmaceutical Companies
- 5.1.2 High Demand for Analytical Testing of Biosimilars and Biologics
5.2 Key Market Restraints:
- 5.2.1 Challenges in Development and Validation of Bioanalytical Methods
5.3 Key Market Opportunities
- 5.3.1 Uninterrupted Growth of Pharmaceuticals Industry
5.4 Future Trends
- 5.4.1 Rising Drug Discovery and Development Activities for Emerging and Rare Diseases
5.5 Impact Analysis:

6. Bioanalytical Testing Services Market - Global Market Analysis

6.1 Bioanalytical Testing Services Market Revenue (US$ Mn), 2022 - 2030

7. Global Bioanalytical Testing Services Market - Revenue and Forecast to 2030 - by Services

7.1 Overview
7.2 Bioanalytical Testing Services Market Revenue Share, by Services 2022 & 2030 (%)
7.3 Pharmacokinetics
- 7.3.1 Overview
- 7.3.2 Pharmacokinetics: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
7.4 Biomarkers
- 7.4.1 Overview
- 7.4.2 Biomarkers: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
7.5 Immunogenicity
- 7.5.1 Overview
- 7.5.2 Immunogenicity: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
7.6 Virology Testing
- 7.6.1 Overview
- 7.6.2 Virology Testing: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  - 7.6.2.1 In-Vitro Virology Testing
    - 7.6.2.1.1 Overview
    - 7.6.2.1.2 In-Vitro Virology Testing: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  - 7.6.2.2 In-Vivo Virology Testing
    - 7.6.2.2.1 Overview
    - 7.6.2.2.2 In-Vivo Virology Testing: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
7.7 Cell-Based Assays
- 7.7.1 Overview
- 7.7.2 Cell-Based Assays: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
7.8 Others
- 7.8.1 Overview
- 7.8.2 Others: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)

8. Global Bioanalytical Testing Services Market - Revenue and Forecast to 2030 - by Disease Indication

8.1 Overview
8.2 Bioanalytical Testing Services Market Revenue Share, by Disease Indication 2022 & 2030 (%)
8.3 Cardiovascular
- 8.3.1 Overview
- 8.3.2 Cardiovascular: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
8.4 Neurological Diseases
- 8.4.1 Overview
- 8.4.2 Neurological Diseases: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
8.5 Autoimmune Disorders
- 8.5.1 Overview
- 8.5.2 Autoimmune Disorders: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
8.6 Respiratory Diseases
- 8.6.1 Overview
- 8.6.2 Respiratory Diseases: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
8.7 Metabolic Disorders
- 8.7.1 Overview
- 8.7.2 Metabolic Disorders: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
8.8 Oncology
- 8.8.1 Overview
- 8.8.2 Oncology: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
8.9 Sexual Health
- 8.9.1 Overview
- 8.9.2 Sexual Health: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
8.10 Bone Disease
- 8.10.1 Overview
- 8.10.2 Bone Disease: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
8.11 Others
- 8.11.1 Overview
- 8.11.2 Others: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)

9. Global Bioanalytical Testing Services Market - Revenue and Forecast to 2030 - by End User

9.1 Overview
9.2 Bioanalytical Testing Services Market Revenue Share, by End User 2022 & 2030 (%)
9.3 Pharmaceutical and Biopharmaceutical Companies
- 9.3.1 Overview
- 9.3.2 Pharmaceutical and Biopharmaceutical Companies: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
9.4 Contract Research Organization (CRO)
- 9.4.1 Overview
- 9.4.2 Contract Research Organization (CRO): Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
9.5 Contract Development And Manufacturing Organization (CDMO)
- 9.5.1 Overview
- 9.5.2 Contract Development And Manufacturing Organization (CDMO): Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
9.6 Others
- 9.6.1 Overview
- 9.6.2 Others: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)

10. Bioanalytical Testing Services Market - Geographical Analysis

10.1 North America Bioanalytical Testing Services Market, Revenue And Forecast To 2030
- 10.1.1 Overview
- 10.1.2 North America Bioanalytical Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
  - 10.1.2.1 North America Bioanalytical Testing Services Market, by Services
    - 10.1.2.1.1 North America Bioanalytical Testing Services Market, by Virology Testing
  - 10.1.2.2 North America Bioanalytical Testing Services Market, by Disease Indication
  - 10.1.2.3 North America Bioanalytical Testing Services Market, by End User
  - 10.1.2.4 North America Bioanalytical Testing Services Market, by Country
  - 10.1.2.5 US
    - 10.1.2.5.1 Overview
    - 10.1.2.5.2 US Bioanalytical Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
    - 10.1.2.5.3 US Bioanalytical Testing Services Market, by Services
    - 10.1.2.5.3.1 US Bioanalytical Testing Services Market, by Virology Testing
    - 10.1.2.5.4 US Bioanalytical Testing Services Market, by Disease Indication
    - 10.1.2.5.5 US Bioanalytical Testing Services Market, by End User
  - 10.1.2.6 Canada
    - 10.1.2.6.1 Overview
    - 10.1.2.6.2 Canada Bioanalytical Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
    - 10.1.2.6.3 Canada Bioanalytical Testing Services Market, by Services
    - 10.1.2.6.3.1 Canada Bioanalytical Testing Services Market, by Virology Testing
    - 10.1.2.6.4 Canada Bioanalytical Testing Services Market, by Disease Indication
    - 10.1.2.6.5 Canada Bioanalytical Testing Services Market, by End User
  - 10.1.2.7 Mexico
    - 10.1.2.7.1 Overview
    - 10.1.2.7.2 Mexico Bioanalytical Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
    - 10.1.2.7.3 Mexico Bioanalytical Testing Services Market, by Services
    - 10.1.2.7.3.1 Mexico Bioanalytical Testing Services Market, by Virology Testing
    - 10.1.2.7.4 Mexico Bioanalytical Testing Services Market, by Disease Indication
    - 10.1.2.7.5 Mexico Bioanalytical Testing Services Market, by End User
10.2 Europe Bioanalytical Testing Services Market, Revenue And Forecast to 2030
- 10.2.1 Overview
- 10.2.2 Europe Bioanalytical Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
  - 10.2.2.1 Europe Bioanalytical Testing Services Market, by Services
    - 10.2.2.1.1 Europe Bioanalytical Testing Services Market, by Virology Testing
  - 10.2.2.2 Europe Bioanalytical Testing Services Market, by Disease Indication
  - 10.2.2.3 Europe Bioanalytical Testing Services Market, by End User
  - 10.2.2.4 Europe Bioanalytical Testing Services Market by Country
  - 10.2.2.5 Germany
    - 10.2.2.5.1 Overview
    - 10.2.2.5.2 Germany Bioanalytical Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
    - 10.2.2.5.3 Germany Bioanalytical Testing Services Market, by Services
    - 10.2.2.5.3.1 Germany Bioanalytical Testing Services Market, by Virology Testing
    - 10.2.2.5.4 Germany Bioanalytical Testing Services Market, by Disease Indication
    - 10.2.2.5.5 Germany Bioanalytical Testing Services Market, by End User
  - 10.2.2.6 UK
    - 10.2.2.6.1 Overview
    - 10.2.2.6.2 UK Bioanalytical Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
    - 10.2.2.6.3 UK Bioanalytical Testing Services Market, by Services
    - 10.2.2.6.3.1 UK Bioanalytical Testing Services Market, by Virology Testing
    - 10.2.2.6.4 UK Bioanalytical Testing Services Market, by Disease Indication
    - 10.2.2.6.5 UK Bioanalytical Testing Services Market, by End User
  - 10.2.2.7 France
    - 10.2.2.7.1 Overview
    - 10.2.2.7.2 France Bioanalytical Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
    - 10.2.2.7.3 France Bioanalytical Testing Services Market, by Services
    - 10.2.2.7.3.1 France Bioanalytical Testing Services Market, by Virology Testing
    - 10.2.2.7.4 France Bioanalytical Testing Services Market, by Disease Indication
    - 10.2.2.7.5 France Bioanalytical Testing Services Market, by End User
  - 10.2.2.8 Italy
    - 10.2.2.8.1 Overview
    - 10.2.2.8.2 Italy Bioanalytical Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
    - 10.2.2.8.3 Italy Bioanalytical Testing Services Market, by Services
    - 10.2.2.8.3.1 Italy Bioanalytical Testing Services Market, by Virology Testing
    - 10.2.2.8.4 Italy Bioanalytical Testing Services Market, by Disease Indication
    - 10.2.2.8.5 Italy Bioanalytical Testing Services Market, by End User
  - 10.2.2.9 Spain
    - 10.2.2.9.1 Overview
    - 10.2.2.9.2 Spain Bioanalytical Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
    - 10.2.2.9.3 Spain Bioanalytical Testing Services Market, by Services
    - 10.2.2.9.3.1 Spain Bioanalytical Testing Services Market, by Virology Testing
    - 10.2.2.9.4 Spain Bioanalytical Testing Services Market, by Disease Indication
    - 10.2.2.9.5 Spain Bioanalytical Testing Services Market, by End User
  - 10.2.2.10 Rest of Europe
    - 10.2.2.10.1 Overview
    - 10.2.2.10.2 Rest of Europe Bioanalytical Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
    - 10.2.2.10.3 Rest of Europe Bioanalytical Testing Services Market, by Services
    - 10.2.2.10.3.1 Rest of Europe Bioanalytical Testing Services Market, by Virology Testing
    - 10.2.2.10.4 Rest of Europe Bioanalytical Testing Services Market, by Disease Indication
    - 10.2.2.10.5 Rest of Europe Bioanalytical Testing Services Market, by End User
10.3 Asia Pacific Bioanalytical Testing Services Market, Revenue And Forecast to 2030
- 10.3.1 Overview
- 10.3.2 Asia Pacific Bioanalytical Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
  - 10.3.2.1 Asia Pacific Bioanalytical Testing Services Market, by Services
    - 10.3.2.1.1 Asia Pacific Bioanalytical Testing Services Market, by Virology Testing
  - 10.3.2.2 Asia Pacific Bioanalytical Testing Services Market, by Disease Indication
  - 10.3.2.3 Asia Pacific Bioanalytical Testing Services Market, by End User
  - 10.3.2.4 Asia Pacific Bioanalytical Testing Services Market by Country
  - 10.3.2.5 China
    - 10.3.2.5.1 Overview
    - 10.3.2.5.2 China Bioanalytical Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
    - 10.3.2.5.3 China Bioanalytical Testing Services Market, by Services
    - 10.3.2.5.3.1 China Bioanalytical Testing Services Market, by Virology Testing
    - 10.3.2.5.4 China Bioanalytical Testing Services Market, by Disease Indication
    - 10.3.2.5.5 China Bioanalytical Testing Services Market, by End User
  - 10.3.2.6 Japan
    - 10.3.2.6.1 Overview
    - 10.3.2.6.2 Japan Bioanalytical Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
    - 10.3.2.6.3 Japan Bioanalytical Testing Services Market, by Services
    - 10.3.2.6.3.1 Japan Bioanalytical Testing Services Market, by Virology Testing
    - 10.3.2.6.4 Japan Bioanalytical Testing Services Market, by Disease Indication
    - 10.3.2.6.5 Japan Bioanalytical Testing Services Market, by End User
  - 10.3.2.7 India
    - 10.3.2.7.1 Overview
    - 10.3.2.7.2 India Bioanalytical Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
    - 10.3.2.7.3 India Bioanalytical Testing Services Market, by Services
    - 10.3.2.7.3.1 India Bioanalytical Testing Services Market, by Virology Testing
    - 10.3.2.7.4 India Bioanalytical Testing Services Market, by Disease Indication
    - 10.3.2.7.5 India Bioanalytical Testing Services Market, by End User
  - 10.3.2.8 Australia
    - 10.3.2.8.1 Overview
    - 10.3.2.8.2 Australia Bioanalytical Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
    - 10.3.2.8.3 Australia Bioanalytical Testing Services Market, by Services
    - 10.3.2.8.3.1 Australia Bioanalytical Testing Services Market, by Virology Testing
    - 10.3.2.8.4 Australia Bioanalytical Testing Services Market, by Disease Indication
    - 10.3.2.8.5 Australia Bioanalytical Testing Services Market, by End User
  - 10.3.2.9 South Korea
    - 10.3.2.9.1 Overview
    - 10.3.2.9.2 South Korea Bioanalytical Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
    - 10.3.2.9.3 South Korea Bioanalytical Testing Services Market, by Services
    - 10.3.2.9.3.1 South Korea Bioanalytical Testing Services Market, by Virology Testing
    - 10.3.2.9.4 South Korea Bioanalytical Testing Services Market, by Disease Indication
    - 10.3.2.9.5 South Korea Bioanalytical Testing Services Market, by End User
  - 10.3.2.10 Rest of Asia Pacific
    - 10.3.2.10.1 Overview
    - 10.3.2.10.2 Rest of Asia Pacific Bioanalytical Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
    - 10.3.2.10.3 Rest of Asia Pacific Bioanalytical Testing Services Market, by Services
    - 10.3.2.10.3.1 Rest of Asia Pacific Bioanalytical Testing Services Market, by Virology Testing
    - 10.3.2.10.4 Rest of Asia Pacific Bioanalytical Testing Services Market, by Disease Indication
    - 10.3.2.10.5 Rest of Asia Pacific Bioanalytical Testing Services Market, by End User
10.4 Middle East & Africa Bioanalytical Testing Services Market, Revenue And Forecast to 2030
- 10.4.1 Overview
- 10.4.2 Middle East & Africa Bioanalytical Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
  - 10.4.2.1 Middle East & Africa Bioanalytical Testing Services Market, by Services
    - 10.4.2.1.1 Middle East & Africa Bioanalytical Testing Services Market, by Virology Testing
  - 10.4.2.2 Middle East & Africa Bioanalytical Testing Services Market, by Disease Indication
  - 10.4.2.3 Middle East & Africa Bioanalytical Testing Services Market, by End User
  - 10.4.2.4 Middle East & Africa Bioanalytical Testing Services Market by Country
  - 10.4.2.5 UAE
    - 10.4.2.5.1 Overview
    - 10.4.2.5.2 UAE Bioanalytical Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
    - 10.4.2.5.3 UAE Bioanalytical Testing Services Market, by Services
    - 10.4.2.5.3.1 UAE Bioanalytical Testing Services Market, by Virology Testing
    - 10.4.2.5.4 UAE Bioanalytical Testing Services Market, by Disease Indication
    - 10.4.2.5.5 UAE Bioanalytical Testing Services Market, by End User
  - 10.4.2.6 Saudi Arabia
    - 10.4.2.6.1 Overview
    - 10.4.2.6.2 Saudi Arabia Bioanalytical Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
    - 10.4.2.6.3 Saudi Arabia Bioanalytical Testing Services Market, by Services
    - 10.4.2.6.3.1 Saudi Arabia Bioanalytical Testing Services Market, by Virology Testing
    - 10.4.2.6.4 Saudi Arabia Bioanalytical Testing Services Market, by Disease Indication
    - 10.4.2.6.5 Saudi Arabia Bioanalytical Testing Services Market, by End User
  - 10.4.2.7 South Africa
    - 10.4.2.7.1 Overview
    - 10.4.2.7.2 South Africa Bioanalytical Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
    - 10.4.2.7.3 South Africa Bioanalytical Testing Services Market, by Services
    - 10.4.2.7.3.1 South Africa Bioanalytical Testing Services Market, by Virology Testing
    - 10.4.2.7.4 South Africa Bioanalytical Testing Services Market, by Disease Indication
    - 10.4.2.7.5 South Africa Bioanalytical Testing Services Market, by End User
  - 10.4.2.8 Rest of Middle East & Africa
    - 10.4.2.8.1 Overview
    - 10.4.2.8.2 Rest of Middle East & Africa Bioanalytical Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
    - 10.4.2.8.3 Rest of Middle East & Africa Bioanalytical Testing Services Market, by Services
    - 10.4.2.8.3.1 Rest of Middle East & Africa Bioanalytical Testing Services Market, by Virology Testing
    - 10.4.2.8.4 Rest of Middle East & Africa Bioanalytical Testing Services Market, by Disease Indication
    - 10.4.2.8.5 Rest of Middle East & Africa Bioanalytical Testing Services Market, by End User
10.5 South & Central America Bioanalytical Testing Services Market, Revenue And Forecast to 2030
- 10.5.1 Overview
- 10.5.2 South & Central America Bioanalytical Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
  - 10.5.2.1 South & Central America Bioanalytical Testing Services Market, by Services
    - 10.5.2.1.1 South & Central America Bioanalytical Testing Services Market, by Virology Testing
  - 10.5.2.2 South & Central America Bioanalytical Testing Services Market, by Disease Indication
  - 10.5.2.3 South & Central America Bioanalytical Testing Services Market, by End User
  - 10.5.2.4 South & Central America Bioanalytical Testing Services Market by Country
  - 10.5.2.5 Brazil
    - 10.5.2.5.1 Overview
    - 10.5.2.5.2 Brazil Bioanalytical Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
    - 10.5.2.5.3 Brazil Bioanalytical Testing Services Market, by Services
    - 10.5.2.5.3.1 Brazil Bioanalytical Testing Services Market, by Virology Testing
    - 10.5.2.5.4 Brazil Bioanalytical Testing Services Market, by Disease Indication
    - 10.5.2.5.5 Brazil Bioanalytical Testing Services Market, by End User
  - 10.5.2.6 Argentina
    - 10.5.2.6.1 Overview
    - 10.5.2.6.2 Argentina Bioanalytical Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
    - 10.5.2.6.3 Argentina Bioanalytical Testing Services Market, by Services
    - 10.5.2.6.3.1 Argentina Bioanalytical Testing Services Market, by Virology Testing
    - 10.5.2.6.4 Argentina Bioanalytical Testing Services Market, by Disease Indication
    - 10.5.2.6.5 Argentina Bioanalytical Testing Services Market, by End User
  - 10.5.2.7 Rest of South & Central America
    - 10.5.2.7.1 Overview
    - 10.5.2.7.2 Rest of South & Central America Bioanalytical Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
    - 10.5.2.7.3 Rest of South & Central America Bioanalytical Testing Services Market, by Services
    - 10.5.2.7.3.1 Rest of South & Central America Bioanalytical Testing Services Market, by Virology Testing
    - 10.5.2.7.4 Rest of South & Central America Bioanalytical Testing Services Market, by Disease Indication
    - 10.5.2.7.5 Rest of South & Central America Bioanalytical Testing Services Market, by End User

11. Pre & Post Covid-19 Impact

11.1 Pre & Post Covid-19 Impact

12. Bioanalytical Testing Services Market Industry Landscape

12.1 Overview
12.2 Growth Strategies in the Bioanalytical Testing Services Market
12.3 Inorganic Growth Strategies
- 12.3.1 Overview
12.4 Organic Growth Strategies
- 12.4.1 Overview

13. Company Profiles

13.1 SGS SA
- 13.1.1 Key Facts
- 13.1.2 Business Description
- 13.1.3 Products and Services
- 13.1.4 Financial Overview
- 13.1.5 SWOT Analysis
- 13.1.6 Key Developments
13.2 Pharmaron Beijing Co Ltd
- 13.2.1 Key Facts
- 13.2.2 Business Description
- 13.2.3 Products and Services
- 13.2.4 Financial Overview
- 13.2.5 SWOT Analysis
- 13.2.6 Key Developments
13.3 Element Materials Technology Group Ltd
- 13.3.1 Key Facts
- 13.3.2 Business Description
- 13.3.3 Products and Services
- 13.3.4 Financial Overview
- 13.3.5 SWOT Analysis
- 13.3.6 Key Developments
13.4 CD BioSciences Inc
- 13.4.1 Key Facts
- 13.4.2 Business Description
- 13.4.3 Products and Services
- 13.4.4 Financial Overview
- 13.4.5 SWOT Analysis
- 13.4.6 Key Developments
13.5 Charles River Laboratories International Inc
- 13.5.1 Key Facts
- 13.5.2 Business Description
- 13.5.3 Products and Services
- 13.5.4 Financial Overview
- 13.5.5 SWOT Analysis
- 13.5.6 Key Developments
13.6 Eurofins Scientific SE
- 13.6.1 Key Facts
- 13.6.2 Business Description
- 13.6.3 Products and Services
- 13.6.4 Financial Overview
- 13.6.5 SWOT Analysis
- 13.6.6 Key Developments
13.7 Labcorp Drug Development Inc
- 13.7.1 Key Facts
- 13.7.2 Business Description
- 13.7.3 Products and Services
- 13.7.4 Financial Overview
- 13.7.5 SWOT Analysis
- 13.7.6 Key Developments
13.8 Syneos Health Inc
- 13.8.1 Key Facts
- 13.8.2 Business Description
- 13.8.3 Products and Services
- 13.8.4 Financial Overview
- 13.8.5 SWOT Analysis
- 13.8.6 Key Developments
13.9 KCAS Bioanalytical and Biomarker Services LLC
- 13.9.1 Key Facts
- 13.9.2 Business Description
- 13.9.3 Products and Services
- 13.9.4 Financial Overview
- 13.9.5 SWOT Analysis
- 13.9.6 Key Developments
13.10 ICON Plc
- 13.10.1 Key Facts
- 13.10.2 Business Description
- 13.10.3 Products and Services
- 13.10.4 Financial Overview
- 13.10.5 SWOT Analysis
- 13.10.6 Key Developments
13.11 Intertek Group Plc
- 13.11.1 Key Facts
- 13.11.2 Business Description
- 13.11.3 Products and Services
- 13.11.4 Financial Overview
- 13.11.5 SWOT Analysis
- 13.11.6 Key Developments

14. Appendix

14.1 About Us
14.2 Glossary of Terms